U.S., Dec. 25 -- ClinicalTrials.gov registry received information related to the study (NCT07301762) titled 'Automated Manual Lymphatic Drainage Therapy to Improve Glymphatic Function in OSA Patients' on Dec. 21.
Brief Summary: The purpose of this research is to investigate whether enhancing systemic lymphatic drainage improves glymphatic function in patients with obstructive sleep apnea (OSA).
Study Start Date: Nov. 24
Study Type: INTERVENTIONAL
Condition:
Obstructive Sleep Apnea (OSA)
OSA
Obstructive Sleep Apnea
Intervention:
DEVICE: Automated manual lymphatic drainage therapy (AMLDT) device
The AMLDT device (Neuroglide) is an FDA-cleared Class II medical device (K202693) for over-the-counter use for pain. It mimics manual lymphat...